Authors/Disclosures
|
Meng Lee, MD
|
No disclosure on file |
|
Jeffrey L. Saver, MD, FAAN
(UCLA Health)
|
Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical. |
|
|
No disclosure on file |
|
Qing Hao, MD
(Duke University School of Medicine)
|
No disclosure on file |
|
Sidney Starkman, MD, FAAN
(UCLA Emergency Medicine Center)
|
No disclosure on file |
|
Latisha Sharma, MD
(UCLA Comprehensive Stroke Center)
|
Dr. Sharma has nothing to disclose. |
|
Doojin Kim, MD
(UCLA)
|
No disclosure on file |
|
Bruce I. Ovbiagele, MD, MSc, FAAN
(San Francisco VA)
|
Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities. |
|
Paul M. Vespa, MD, FAAN
(UCLA)
|
Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Vespa has received research support from NIH. Dr. Vespa has received intellectual property interests from a discovery or technology relating to health care. |
|
Michael T. Froehler, MD, PhD
|
No disclosure on file |
|
Matthew Tenser, MD
(University of Southern California)
|
No disclosure on file |
|
|
No disclosure on file |
|
Patrick Waters, PhD
(Oxford Autoimmune Neurology Diagnostic Lab - Nuffield Clinical Neurosciences)
|
Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Nestor R. Gonzalez, MD
|
Nestor R. Gonzalez, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Nestor R. Gonzalez, MD has received research support from National Institutes of Health. The institution of Nestor R. Gonzalez, MD has received research support from American Heart Associaton. |
|
Fernando Vinuela
(UCLA Medical Ctr)
|
No disclosure on file |
|
David S. Liebeskind, MD, FAAN
(Neurovascular Imaging Research Core at UCLA)
|
Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker. |